{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T19:32:36Z","timestamp":1783798356774,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:00:00Z","timestamp":1563321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ejpb.2019.07.008","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T11:55:55Z","timestamp":1562932555000},"page":"334-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["A spray freeze dried micropellet based formulation proof-of-concept for a yellow fever vaccine candidate"],"prefix":"10.1016","volume":"142","author":[{"given":"Didier","family":"Cl\u00e9net","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Hourquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Woinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Ponceblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Vangelisti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2019.07.008_b0005","series-title":"Vaccines","first-page":"915","article-title":"38 - Yellow fever vaccine","author":"Monath","year":"2013"},{"key":"10.1016\/j.ejpb.2019.07.008_b0010","unstructured":"P.F. Chouvenc, A., WO\/2009\/109550, Process for stabilizing an adjuvant containing vaccine composition, 2009."},{"key":"10.1016\/j.ejpb.2019.07.008_b0015","unstructured":"P. S. Tschessalov, http:\/\/www.lyo-garmisch.de\/de\/Home\/Scientific-Program\/September-20_-2018.html, 2018 (accessed 12.13.18)."},{"key":"10.1016\/j.ejpb.2019.07.008_b0020","doi-asserted-by":"crossref","unstructured":"J. Eggers, E. Villermaux, Physics of Liquid Jets, 2008.","DOI":"10.1088\/0034-4885\/71\/3\/036601"},{"key":"10.1016\/j.ejpb.2019.07.008_b0025","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2015.04.053","article-title":"Pharmaceutical spray freeze drying","volume":"488","author":"Wanning","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.07.008_b0030","unstructured":"USP<429>, United States Pharmacopeia, Laser Diffraction Measurement of Particle Size, 2008."},{"key":"10.1016\/j.ejpb.2019.07.008_b0035","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1002\/jps.24117","article-title":"Advanced kinetic analysis as a tool for formulation development and prediction of vaccine stability","volume":"103","author":"Cl\u00e9net","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.07.008_b0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tca.2014.01.005","article-title":"Prediction of thermal stability of materials by modified kinetic and model selection approaches based on limited amount of experimental points","volume":"579","author":"Roduit","year":"2014","journal-title":"Thermochim. Acta"},{"key":"10.1016\/j.ejpb.2019.07.008_b0045","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejpb.2018.01.005","article-title":"Accurate prediction of vaccine stability under real storage conditions and during temperature excursions","volume":"125","author":"Cl\u00e9net","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.07.008_b0050","unstructured":"S. Pramanick, V. Chandel, D. Singodia, Excipient Selection in Parenteral Formulation Development, 2013."},{"key":"10.1016\/j.ejpb.2019.07.008_b0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejpb.2018.07.011","article-title":"Parenteral protein formulations: An overview of approved products within the European Union","volume":"131","author":"Gervasi","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.07.008_b0060","unstructured":"S. Rushil, M. Priti, Freeze dried injectable drug product development: Selection of non functional additives, 2014."},{"key":"10.1016\/j.ejpb.2019.07.008_b0065","doi-asserted-by":"crossref","unstructured":"R. Strickley, Solubilizing Excipients in Oral and Injectable Formulations, 2004.","DOI":"10.1023\/B:PHAM.0000016235.32639.23"},{"key":"10.1016\/j.ejpb.2019.07.008_b0070","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1080\/03639045.2018.1483392","article-title":"Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics","volume":"44","author":"Rayaprolu","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2019.07.008_b0075","doi-asserted-by":"crossref","unstructured":"B. Chang, C. Randall, Use of thermal analysis to optimize protein lyophilization, 1992.","DOI":"10.1016\/0011-2240(92)90067-C"},{"key":"10.1016\/j.ejpb.2019.07.008_b0080","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1023\/A:1016006106821","article-title":"Maltodextrins as lyoprotectants in the lyophilization of a model protein","volume":"13","author":"Corveleyn","year":"1996","journal-title":"LDH, Pharmaceut. Res."},{"key":"10.1016\/j.ejpb.2019.07.008_b0085","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0260-8774(96)00058-1","article-title":"Glassy state in relation to the thermal inactivation of the enzyme invertase in amorphous dried matrices of trehalose, maltodextrin and PVP","volume":"30","author":"Schebor","year":"1996","journal-title":"J. Food Eng."},{"key":"10.1016\/j.ejpb.2019.07.008_b0090","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1023\/A:1018945117471","article-title":"Non-isothermal and isothermal crystallization of sucrose from the amorphous state","volume":"11","author":"Saleki-Gerhardt","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.07.008_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(00)00423-3","article-title":"Lyophilization and development of solid protein pharmaceuticals","volume":"203","author":"Wang","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.07.008_b0100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejpb.2005.02.013","article-title":"Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage","volume":"60","author":"Passot","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.07.008_b0105","doi-asserted-by":"crossref","unstructured":"B. Aldous, F. Franks, A. Greer, Diffusion of water within an amorphous carbohydrate, 1997.","DOI":"10.1023\/A:1018584812561"},{"key":"10.1016\/j.ejpb.2019.07.008_b0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4103\/2231-4040.90877","article-title":"Fast disintegrating tablets: Opportunity in drug delivery system","volume":"2","author":"Parkash","year":"2011","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.ejpb.2019.07.008_b0115","unstructured":"Regulatory control of freeze dried products: Importance and evaluation of residual moisture in Lyophilization\/Freeze drying of Pharmaceutical & Biological Products, in: L.R.J. May (Ed.) Lyophilization\/Freeze drying of Pharmaceutical & Biological Products, Dekker, New York, 2004, pp. 199\u2013230."},{"key":"10.1016\/j.ejpb.2019.07.008_b0120","first-page":"19","article-title":"Excipients use in parenteral and lyophilized formulation development, open science","volume":"3","author":"Yasir Mehmood","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2019.07.008_b0125","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11095-004-1198-y","article-title":"Raffinose crystallization during freeze-drying and its impact on recovery of protein activity","volume":"22","author":"Chatterjee","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.07.008_b0130","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1016\/j.vaccine.2015.08.085","article-title":"Freeze-drying of live virus vaccines: A review","volume":"33","author":"Hansen","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2019.07.008_b0135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/pro.3","article-title":"Effect of trehalose on protein structure","volume":"18","author":"Jain","year":"2008","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejpb.2019.07.008_b0140","doi-asserted-by":"crossref","first-page":"7456","DOI":"10.1016\/j.vaccine.2011.07.054","article-title":"Novel formulations enhance the thermal stability of live-attenuated flavivirus vaccines","volume":"29","author":"Wiggan","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2019.07.008_b0145","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.vaccine.2017.04.086","article-title":"Combined semi-empirical screening and design of experiments (DOE) approach to identify candidate formulations of a lyophilized live attenuated tetravalent viral vaccine candidate","volume":"36","author":"Patel","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2019.07.008_b0150","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.vaccine.2009.11.024","article-title":"Heat-stable measles vaccine produced by spray drying","volume":"28","author":"Ohtake","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2019.07.008_b0155","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.xphs.2018.04.019","article-title":"Urea improves stability of inactivated polio vaccine serotype 3 during lyophilization and storage in dried formulations","volume":"107","author":"Qi","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.07.008_b0160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4172\/1948-593X.1000094","article-title":"The potency of yellow fever vaccines sold in open markets in eastern Nigeria","volume":"5","author":"Chukwuma","year":"2013","journal-title":"J. Bioanal. Biomed."},{"key":"10.1016\/j.ejpb.2019.07.008_b0165","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1586\/14760584.2014.923761","article-title":"Tools and approaches to ensure quality of vaccines throughout the cold chain","volume":"13","author":"Kartoglu","year":"2014","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ejpb.2019.07.008_b0170","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejpb.2018.08.006","article-title":"Biophysical virus particle specific characterization to sharpen the definition of virus stability","volume":"132","author":"Cl\u00e9net","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.07.008_b0175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0040-6031(76)80056-1","article-title":"Differential scanning calorimetry of epoxy cure: isothermal cure kinetics","volume":"14","author":"Sourour","year":"1976","journal-title":"Thermochim. Acta"},{"key":"10.1016\/j.ejpb.2019.07.008_b0180","doi-asserted-by":"crossref","first-page":"10790","DOI":"10.1021\/bi800726m","article-title":"Fitting yeast and mammalian prion aggregation kinetic data with the Finke-Watzky two-step model of nucleation and autocatalytic growth","volume":"47","author":"Watzky","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejpb.2019.07.008_b0185","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejpb.2016.04.010","article-title":"Spectroscopic evaluation of a freeze-dried vaccine during an accelerated stability study","volume":"104","author":"Hansen","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.07.008_b0190","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1745-4530.2009.00425.x","article-title":"Bootstrap confidence intervals for the kinetic parameters of degradation of anthocyanins in grape pomace","volume":"34","author":"Mishra","year":"2011","journal-title":"J. Food Process Eng."},{"key":"10.1016\/j.ejpb.2019.07.008_b0195","unstructured":"Vaccine Vial Monitor - WHO\/PQS\/E06\/IN05.2, 2006."},{"key":"10.1016\/j.ejpb.2019.07.008_b0200","unstructured":"World Health Organization, Requirements for yellow fever vaccine, Expert committee on biological standardization, technical report series 46th Report. Genova. 840: annex2, 1998."},{"key":"10.1016\/j.ejpb.2019.07.008_b0205","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.3390\/molecules24122217","article-title":"Continuous monitoring of shelf lives of materials by application of data loggers with implemented kinetic parameters","volume":"24","author":"Roduit","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2019.07.008_b0210","doi-asserted-by":"crossref","unstructured":"J.S.M. Yuen, K.L. Choy, H. Lam, Y.P. Tsang, An Intelligent-Internet of Things (IoT) Outbound Logistics Knowledge Management System for Handling Temperature Sensitive Products, 2018.","DOI":"10.4018\/IJKSS.2018010102"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641119303546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641119303546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:38:10Z","timestamp":1760546290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641119303546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":42,"alternative-id":["S0939641119303546"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.07.008","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A spray freeze dried micropellet based formulation proof-of-concept for a yellow fever vaccine candidate","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}